Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H19NO |
Molecular Weight | 253.3389 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(NCC1=CC=CC=C1)C(=O)C2=CC=C(C)C=C2
InChI
InChIKey=KWHZRPBDEAQYDE-UHFFFAOYSA-N
InChI=1S/C17H19NO/c1-13-8-10-16(11-9-13)17(19)14(2)18-12-15-6-4-3-5-7-15/h3-11,14,18H,12H2,1-2H3
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL238 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23261499 |
|||
Target ID: CHEMBL222 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23261499 |
|||
Target ID: CHEMBL228 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23261499 |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Benzedrone
Created by
admin on Sat Dec 16 10:51:46 GMT 2023 , Edited by admin on Sat Dec 16 10:51:46 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1225617-75-3
Created by
admin on Sat Dec 16 10:51:46 GMT 2023 , Edited by admin on Sat Dec 16 10:51:46 GMT 2023
|
PRIMARY | |||
|
V6Z5G5VE87
Created by
admin on Sat Dec 16 10:51:46 GMT 2023 , Edited by admin on Sat Dec 16 10:51:46 GMT 2023
|
PRIMARY | |||
|
300000047374
Created by
admin on Sat Dec 16 10:51:46 GMT 2023 , Edited by admin on Sat Dec 16 10:51:46 GMT 2023
|
PRIMARY | |||
|
DTXSID401017094
Created by
admin on Sat Dec 16 10:51:46 GMT 2023 , Edited by admin on Sat Dec 16 10:51:46 GMT 2023
|
PRIMARY | |||
|
57493771
Created by
admin on Sat Dec 16 10:51:46 GMT 2023 , Edited by admin on Sat Dec 16 10:51:46 GMT 2023
|
PRIMARY | |||
|
BENZEDRONE
Created by
admin on Sat Dec 16 10:51:46 GMT 2023 , Edited by admin on Sat Dec 16 10:51:46 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD